International Journal of Drug Policy
Volume 17, Issue 2 , Pages 61-69 , March 2006

Harm reduction by a “user-run” organization: A case study of the Vancouver Area Network of Drug Users (VANDU)

  • Thomas Kerr

      Affiliations

    • The Canadian HIV/AIDS Legal Network, 417 Rue Saint Pierre, Suite 408 Montreal, Que., Canada H2Y 2M4
    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, University of British Columbia, Canada
    • Corresponding Author InformationCorresponding author at: The Canadian HIV/AIDS Legal Network, 417 Rue Saint Pierre, Suite 408 Montreal, Que., Canada H2Y 2M4. Tel.: +1 514 397 6828x222; fax: +1 514 397 8570.
  • ,
  • Will Small

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, University of British Columbia, Canada
  • ,
  • Wallace Peeace

      Affiliations

    • Vancouver Area Network of Drug Users (VANDU), Canada
  • ,
  • David Douglas

      Affiliations

    • Vancouver Area Network of Drug Users (VANDU), Canada
  • ,
  • Adam Pierre

      Affiliations

    • Vancouver Area Network of Drug Users (VANDU), Canada
  • ,
  • Evan Wood

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, University of British Columbia, Canada
    • Department of Health Care and Epidemiology, University of British Columbia, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0955-3959(06)00006-5

doi: 10.1016/j.drugpo.2006.01.003

International Journal of Drug Policy
Volume 17, Issue 2 , Pages 61-69 , March 2006